Last updated on November 2017

A Double Blind, Placebo- and Active Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder


Brief description of study

A Double Blind, Placebo- and Active Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder

Detailed Study Description

A clinical research study to evaluate the safety, effectiveness and tolerability of an investigational drug for adolescents 12 - 17 years of age with Major Depressive Disorder.

Clinical Study Identifier: TX8310

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Karen Godoy

Pacific Clinical Research Medical Group
Upland, CA USA
  Connect »